When it comes to innovative technology, the healthcare space has always been notoriously slow, making them the proverbial “old dog.”
But when you have a “new trick” with data backing up its efficacy, sometimes that old dog sits up and takes notice. Just ask Peter Bianco, Founder & Chairman at OsteoApp.ai.
Peter’s company took a non-AI proven screening product and enhanced it with artificial intelligence, filling a long-neglected need in the orthopedic space.
The solution proved to be a more convenient and effective option for both the healthcare industry and patients at risk for osteoporosis.
Peter takes the time to highlight his commercialization journey - one that utilized serendipity, strategic steps, and innovative vision on its way to disproving that old saying that you can’t teach an old dog new tricks.
Here are the show highlights:
- The power of collaboration (5:58)
- Navigating the gap between pilots (10:16)
- How to price revolutionary innovations (15:29)
- When small steps are better (17:53)
- Education’s role in commercialization (22:47)
- The benefit of a strategic lead investor (29:08)
I've spoken with dozens of health innovators, and nearly everyone is trying to figure out their best pivot strategy. But they don't know what to change, how to pivot, or if their new pivot strategy is the right move.
So I went into overdrive putting together a clear, actionable 5-step worksheet that will help you quickly define your most viable and profitable pivot path through the COVID crisis. And I’m giving it to you for FREE — no strings attached at legacy-dna.com/pivot
Peter T. Bianco is Founder & Chairman at OsteoApp.ai, a company that provides a novel, cost-effective screening method for early detection of osteoporosis, intervention and fracture prevention.
A serial entrepreneur with nearly 30 years of experience in research and product development, sales, and marketing in the healthcare field, Peter started as a product development engineer and worked his way up to senior marketing director with Johnson & Johnson Orthopedics.
From there, he became CEO of a groundbreaking Venture-backed internet-based eHealth company that was acquired by Medtronic.
Peter is a member of the Orthopedic Research Society (ORS) and holds four U.S. and European patents relating to orthopedic joint reconstruction devices.
He earned an MBA from Suffolk University in Boston, Massachusetts and a bachelor's degree in human physiology from the University of Minnesota.